Similar articles

• Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene.

  Rabacchi C, D'Addato S, Palmisano S, Lucchi T, Bertolini S, Calandra S, Tarugi P. Rabacchi C, et al. J Clin Lipidol. 2016 Jul-Aug;10(4):915-921.e4. doi: 10.1016/j.jacl.2016.03.009. Epub 2016 Mar 23. J Clin Lipidol. 2016. PMID: 27578123
• Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.

  Caddeo A, Mancina RM, Pirazzi C, Russo C, Sasidharan K, Sandstedt J, Maurotti S, Montalcini T, Pujia A, Leren TP, Romeo S, Pingitore P. Caddeo A, et al. Nutr Metab Cardiovasc Dis. 2018 Feb;28(2):158-164. doi: 10.1016/j.numecd.2017.11.003. Epub 2017 Nov 22. Nutr Metab Cardiovasc Dis. 2018. PMID: 29288010
• A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome.

  Paquette M, Hegele RA, Paré G, Baass A. Paquette M, et al. J Clin Lipidol. 2018 Mar-Apr;12(2):506-510. doi: 10.1016/j.jacl.2018.01.011. Epub 2018 Jan 31. J Clin Lipidol. 2018. PMID: 29452893
• Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6.

  Gilbert B, Rouis M, Griglio S, de Lumley L, Laplaud P. Gilbert B, et al. Ann Genet. 2001 Jan-Mar;44(1):25-32. doi: 10.1016/s0003-3995(01)01037-1. Ann Genet. 2001. PMID: 11334614 Review.
• Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".

  Moulin P, Dufour R, Averna M, Arca M, Cefalù AB, Noto D, D'Erasmo L, Di Costanzo A, Marçais C, Alvarez-Sala Walther LA, Banach M, Borén J, Cramb R, Gouni-Berthold I, Hughes E, Johnson C, Pintó X, Reiner Ž, van Lennep JR, Soran H, Stefanutti C, Stroes E, Bruckert E. Moulin P, et al. Atherosclerosis. 2018 Aug;275:265-272. doi: 10.1016/j.atherosclerosis.2018.06.814. Epub 2018 Jun 18. Atherosclerosis. 2018. PMID: 29980054 Review.